ACTAVIS INC FDA Approval ANDA 202603

ANDA 202603

ACTAVIS INC

FDA Drug Application

Application #202603

Documents

Letter2015-06-11

Application Sponsors

ANDA 202603ACTAVIS INC

Marketing Status

Prescription001

Application Products

001CAPSULE;ORAL10MG0METHOXSALENMETHOXSALEN

FDA Submissions

UNKNOWN; ORIG1AP2015-06-09

Submissions Property Types

ORIG1Null17

TE Codes

001PrescriptionAB

CDER Filings

ACTAVIS INC
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 202603
            [companyName] => ACTAVIS INC
            [docInserts] => ["",""]
            [products] => [{"drugName":"METHOXSALEN","activeIngredients":"METHOXSALEN","strength":"10MG","dosageForm":"CAPSULE;ORAL","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"}]
            [labels] => 
            [originalApprovals] => [{"actionDate":"06\/09\/2015","submission":"ORIG-1","actionType":"Approval","submissionClassification":"","reviewPriority":"","inserts":"[{\"name\":\"Letter (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/appletter\\\/2015\\\/202603Orig1s000ltr.pdf\"}]","notes":"> Label is not available on this site."}]
            [supplements] => 
            [actionDate] => 2015-06-09
        )

)

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.